Yvonne Angel

Yvonne has over 16 years of experience in the pharmaceutical industry. She has led research teams at Eli Lilly, Wyeth, Affymax, Ipsen Bioscience and is currently working on consulting projects through her own consulting firm, Picotide Technologies. Her primary expertise is in design, synthesis and lead optimization of novel peptides, peptidomimetics and peptide conjugates. Yvonne received her PhD in Medicinal Chemistry at the University of Wisconsin-Madison and post-doctoral work at the University of Minnesota.